glp-1 drugs key developments 2025 Weight Loss Drugs: How Semaglutide & Tirzepatide Redefine Obesity Care GLP-1 Market Size, Share |
Description
Similar content being viewed by others Introduction/background Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs) are a class of medications increasingly utilized in the treatment of type 2 diabetes and, more recently, obesity (Nathan et al
These developments will have implications for numerous stakeholders within the industry
Johns Hopkins MD
Other Diabetes Medications: Metformin, SGLT2 inhibitors, and DPP-4 inhibitors may be suitable alternatives
Find your perfect match
